Trajenta, Linagliptin Tablets 5 mg, Type 2 diabetes blood sugar control medication, 30 tablets

Trajenta is a medication containing Linagliptin 5 mg, designed for the management of blood sugar levels in individuals with type 2 diabetes. Linagliptin, the active ingredient, works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones in the body. These hormones help regulate blood sugar by stimulating the release of insulin and reducing the production of glucagon. By controlling blood sugar levels, Trajenta helps prevent complications associated with diabetes. The tablets are easy to take and are typically prescribed as part of a comprehensive treatment plan for diabetes management.